Intrinsic Value

The intrinsic value of Shandong Teamgene Technology Co Ltd (603151) under the Base Case is 20.9 CNY per share. Compared with the current market price of 17.42 CNY, the stock appears Undervalued by 17% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥20.9
Undervaluation 17%
Intrinsic Value
Price ¥17.42
S

Shandong Teamgene Technology Co Ltd is valued in line with its history. A discount of this size has been typical over the past 4 years.

Monitor Shandong Teamgene Technology Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥16.72
Get notified when the price drops into your buy zone
Intrinsic Value ¥20.9
Current Price ¥17.42
Margin of Safety 20% ¥16.72
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Shandong Teamgene Technology Co Ltd

Fundamental Analysis

What Shandong Teamgene Technology Does

Food Products Consumer Staples

Shandong Teamgene Technology makes molecular diagnostic products and gene-testing tools for the medical market. Its business is built around reagents, test kits, and related products that help labs detect diseases from biological samples, especially in areas like infection, genetic screening, and other clinical testing workflows.

Headquarters
China CN
Employees
1 348
IPO date
Oct 19, 2022
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Shandong Teamgene Technology Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Shandong Teamgene Technology Co Ltd stock?

The intrinsic value for Shandong Teamgene Technology Co Ltd (603151) under the Base Case is 20.9 CNY.

Is Shandong Teamgene Technology Co Ltd stock undervalued or overvalued?

Compared with the current market price of 17.42 CNY, the stock appears Undervalued by 17% .

Back to Top